Revenue
No reported data
Skye Bioscience, Inc. (SKYE)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $42.4M | $18.7M | $5.8M | $6.0M | $2.9M | $1.9M | $2.2M | $329,966 | $311,302 | $939,040 | $576,093 | $227,500 | — | — |
| Operating expenses | $58.2M | $30.2M | $34.7M | $18.3M | $7.8M | $6.3M | $6.6M | $4.7M | $3.9M | $4.5M | $4.3M | $2.7M | $347,168 | $12,126 |
| Operating income | −$58.2M | −$30.2M | −$34.7M | −$18.3M | −$7.8M | −$6.3M | −$6.6M | −$4.7M | −$3.9M | −$4.5M | −$4.3M | −$2.7M | −$7,242 | $4,117 |
| EBITDAderived | −$57.4M | −$29.9M | −$34.6M | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$55.9M | −$26.6M | −$37.6M | −$19.5M | −$8.5M | −$6.6M | $1.1M | −$19.2M | −$3.1M | −$3.2M | −$4.8M | −$2.7M | −$3,782 | $4,509 |
| Basic EPSper diluted share | -$1.41 | -$0.73 | -$5.37 | -$8.77 | -$0.02 | -$0.03 | $0.01 | -$0.16 | -$0.11 | -$0.17 | -$0.29 | -$0.27 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$1.41 | -$0.73 | -$5.37 | -$8.77 | -$0.02 | -$0.03 | -$0.05 | -$0.16 | -$0.11 | -$0.17 | -$0.29 | -$0.27 | $0.00 | $0.00 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 22, 2025Form 4 | Schwab Andrew J.Director,TenPercentOwner | SellCommon Stock · indirect | 6.5K | $3.42 | $22.1K | 57.5K |
| Aug 22, 2025Form 4 | Schwab Andrew J.Director,TenPercentOwner | SellCommon Stock · indirect | 164.0K | $3.42 | $560.8K | 1.46M |
| Aug 22, 2025Form 4 | ROCKLAGE SCOTT M +7TenPercentOwner | SellCommon Stock · indirect | 6.5K | $3.42 | $22.1K | 57.5K |
| Aug 22, 2025Form 4 | ROCKLAGE SCOTT M +7TenPercentOwner | SellCommon Stock · indirect | 164.0K | $3.42 | $560.8K | 1.46M |
| Aug 21, 2025Form 4 | Schwab Andrew J.Director,TenPercentOwner | SellCommon Stock · indirect | 2.3K | $3.57 | $8.3K | 64.0K |